HOME >> BIOLOGY >> NEWS
Laying sleeping sickness to rest

The parasite that leads to sleeping sickness can be lulled to sleep itself using a newly discovered pathway, according to research published online this week in EMBO reports. Trypanosoma brucei is a parasite that causes sleeping sickness resulting in neurological damage and death.

Shulamit Michaeli and colleagues describe a pathway in T. brucei parasites that they named SLS (SL-RNA silencing). Triggering this pathway shuts down the synthesis of a crucial RNA molecule, which halts the production of messenger RNAs and leads to the parasites death. Inducing SLS could therefore be a novel way to eradicate parasites and prevent sleeping sickness - trypanosomiasis. The researchers also believe this could have implications for related parasites and diseases, such as Leishmania and leishmaniasis and Trypanosoma cruzi and Chagas disease.

Sleeping sickness affects humans and livestock, and is endemic in sub-Saharan Africa where it is estimated to affect as many as 70,000 people. Leishmaniasis is estimated to affect millions of individuals throughout the world, and can lead to skin lesions, tissue damage, fever, blindness and death. Chagas disease affects 16-18 million people across the Americas, and can cause intestinal complications, neurological disorders, heart damage and death. Although drugs are available to treat these diseases, their use is hampered by toxicity and undesirable side effects, difficulties in administering treatment, an increase in drug resistance, and high costs.


'"/>

Contact: Shulamit Michaeli
michaes@mail.biu.ac.il
972-353-18068
European Molecular Biology Organization
19-Mar-2007


Page: 1

Related biology news :

1. Pioneering research on sleeping sickness wins MERIAL Award for Parasitology
2. New study suggests promising drug combinations for sleeping sickness
3. Resistance and genetic sensitivity to sleeping sickness
4. A large step forward in the fight against African sleeping sickness
5. Waking a sleeping virus
6. Employee with sleeping disorder has to work extra hard
7. Research warns against sleeping in contact lenses
8. Sleeping sickness parasite shows how cells divide their insides

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:7/2/2020)... ... July 01, 2020 , ... AltruBio ... findings of Neihulizumab, a biologic for the treatment of steroid-refractory acute graft-versus-host disease ... hemato-oncologist Dr. Paul J Martin of the Fred Hutchinson Cancer Research Center, this ...
(Date:6/28/2020)... ... June 25, 2020 , ... ... biopharmaceutical R&D, today announced that it has entered into a multi-year contract ... (Multiclonics®), to support their translational and clinical research strategy to discover and ...
(Date:6/23/2020)... (PRWEB) , ... June 23, 2020 , ... ... supporting sustainable healthcare, and Renovagen Ltd, a UK supplier and manufacturer of innovative ... to support testing operations in the fight against the COVID-19 pandemic in Zambia. ...
Breaking Biology News(10 mins):
(Date:8/12/2020)... ... August 11, 2020 , ... ... making available for free its new white paper – Simulated Transport Methodologies. ... into today’s biologics licensing application (BLA). In response, Modality Solutions shares an ...
(Date:7/31/2020)... , ... July 29, 2020 , ... R3 Stem Cell ... for only $3950. With 50 million stem cells total, patients may choose which extremities ... therapy works for arthritic joints (BMC Musculoskelet Disord. 2016). At R3 International, umbilical cord ...
(Date:7/31/2020)... , ... July 29, 2020 , ... eSource has long ... This webinar will cover the history of eSource, the reasons it did not take ... to wearables, to site source, the industry is moving towards capturing data electronically for ...
(Date:7/18/2020)... ... July 16, 2020 , ... “We are thrilled to ... Bioactives. “It’s the only technology of its kind on the market and we were ... with the protective capacity of traditional cultured ingredients, creating a natural way to extend ...
Breaking Biology Technology:
Cached News: